# Ottawa Hospital Research Institute

Organization · id `cardio:org-ottawa-hospital-research-institute` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 05jtef216](<https://ror.org/05jtef216>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 9 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 05jtef216 by an exact name.

## The registry's words

- Sponsor name: Ottawa Hospital Research Institute
- Sponsor class: OTHER
- ROR name: Ottawa Hospital Research Institute

## Connected pages

- Sponsors: Trial of Electrical Versus Pharmacological Cardioversion for RAFF in the ED (`cardio:ct-nct01891058`)
- Sponsors: Consolidating Tools for Outcomes in Resuscitation (`cardio:ct-nct02676024`)
- Sponsors: Thromboprophylaxis With Rivaroxaban In Patients With Malignancy and Central Venous Lines (`cardio:ct-nct03506815`)
- Sponsors: Statins for Venous Event Reduction in Patients With Venous Thromboembolism (`cardio:ct-nct04319627`)
- Sponsors: RAFF4 Trial: Vernakalant vs. Procainamide for Acute Atrial Fibrillation in the Emergency Department (`cardio:ct-nct04485195`)
- Sponsors: COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation (`cardio:ct-nct04642430`)
- Sponsors: International Care Bundle Evaluation in Cerebral Hemorrhage Research (`cardio:ct-nct06429332`)
- Sponsors: Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial) (`cardio:ct-nct06440694`)
- Sponsors: Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis (`cardio:ct-nct06603870`)

## Provenance

Content hash: 58dbde907b937805a9387491a1b40a471e7b7e554cca04b7cc612d14b6e89440
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
